文献速递胸部CT

临床T1aN0M0肺癌:基于高分辨率CT表现的临床病理模式与肿瘤学结局差异

Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.
PubMed 文献 · Eur Radiol · 2021-04-15

该回顾性研究纳入257例临床T1aN0M0肺癌患者,按HRCT上实性成分大小分为纯磨玻璃结节(直径>3cm)、部分实性和纯实性三组,比较其临床病理特征与预后。结果显示三组5年无复发生存率和总生存率存在显著差异,纯实性组预后最差;术前CEA水平和实性成分占比(CTR)是独立预后因素,CTR预测术后复发的AUC为0.784,截断值0.5。

要点

  • HRCT上纯磨玻璃和部分实性亚型的c-T1aN0M0肺癌预后极佳,可视为「早期」肺癌。
  • 纯实性结节即使亚厘米大小,术后复发风险仍较高,不应简单视为早期。
  • 术前CEA水平和CTR是预测复发的独立预后因素,CTR截断值0.5。

核心结论

  • c-T1aN0M0肺癌中,纯磨玻璃和部分实性亚型预后极佳,可考虑为「早期」癌症;纯实性表现者尽管亚厘米大小,仍与高复发风险相关。

研究设计与样本

  • 回顾性纳入257例临床T1aN0M0肺癌患者,依据HRCT上实性成分大小分为纯磨玻璃结节(直径>3cm,n=19)、部分实性(n=174)和纯实性(n=64)三组,采用Cox比例风险模型评估预后因素。

关键影像表现/征象

  • 纯磨玻璃、部分实性和纯实性三组的5年无复发生存率分别为100%、95.4%和76.6%(p<0.0001),总生存率分别为100%、98.9%和87.5%(p<0.0001)。

诊断标准与关键数值

  • CTR预测术后复发的AUC为0.784(95%CI 0.697-0.869),截断值为0.5。
  • 术前CEA水平和CTR是与RFS和OS相关的独立显著预后因素。

临床应用与阅片要点

  • 阅片时应根据HRCT上实性成分大小对c-T1aN0M0肺癌进行亚型分类,并报告CTR,尤其注意纯实性结节即使亚厘米也需警惕复发风险。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To elucidate the clinicopathological characteristics and oncological outcomes of clinical T1aN0M0 (c-T1N0M0) lung cancer based on the newest 8th TNM classification.

METHODS: A total of 257 patients with c-T1aN0M0 lung cancer were retrospectively included in this study. According to the solid component size manifesting on the high-resolution computed tomography (HRCT), all lesions were classified as the pure ground-glass nodule (pure-GGN) with a diameter > 3 cm (n = 19), part-solid (n = 174), and pure-solid (n = 64) groups. We evaluated the prognostic impact of clinicopathologic variables including radiological presentations by establishing Cox proportional hazards model.

RESULTS: When we evaluated the prognostic impact based on the radiological subtypes, the 5-year recurrence-free survival (RFS) and overall survival (OS) were significantly different among pure-GGN, part-solid, and pure-solid groups (RFS: 100% versus 95.4% versus 76.6%, p < 0.0001; OS: 100% versus 98.9% versus 87.5%, p < 0.0001). Cox regression analysis revealed the preoperative carcinoembryonic antigen (CEA) level and consolidation tumor ratio (CTR) were independently significant prognosticators related to RFS and OS. Furthermore, a receiver operating characteristic (ROC) verified the CTR (area under ROC [AUC] 0.784, 95%CI 0.697-0.869) was equipped with good performance to predict the postoperative recurrence with a cutoff point at 0.5. Lung cancer with higher CTR tended to be associated with lower survival in the c-T1aN0M0 stage.

CONCLUSIONS: For the c-T1aN0M0 lung cancer, pulmonary nodules manifested as the pure-GGN and part-solid subtypes had an excellent prognosis and may be considered as the "early-stage" cancer, whereas those with pure-solid appearance were associated with the high risk of recurrence despite the sub-centimeter size.

KEY POINTS: • Radiological subtypes could further stratify the risk of lung cancer in cT1a. • Sub-solid nodule has a favorable survival in c-T1a lung cancer, whereas pure-solid nodule is not always "early-stage" lung cancer and is relatively prone to postoperative recurrence despite the sub-centimeter size. • The preoperative CEA level and CTR are valuable prognosticators to predict the recurrence in c-T1a lung cancer.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Sun K, You A, Wang B, et al. Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography. Eur Radiol. 2021. PMID: 33860370. doi:10.1007/s00330-021-07865-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。